| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/28/2004 | CN1516690A Heterocyclic derivatives and medicines |
| 07/28/2004 | CN1516689A Process for production of piperidine derivative fexofenadine |
| 07/28/2004 | CN1516687A 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 07/28/2004 | CN1516684A Deuterated N-substituted and alpha-substituted diphenylalkoxy acetic acid amino alkyl esters and medicaments containing these compounds |
| 07/28/2004 | CN1516601A Orally deliverable pharmaceutical composition comprising drug of low water solubility (cox-2 inhibitor), solvent, fatty acid and organic amine |
| 07/28/2004 | CN1516600A Combinatino medicament for treatment of neoplastic diseases |
| 07/28/2004 | CN1516599A Method for joint treatment of chronic hepatitis C infection using ribavirin-polyvinyl glycol interferon alpha |
| 07/28/2004 | CN1516592A Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancers, diabetes, premenstrual syndrome and transdermal transport |
| 07/28/2004 | CN1516590A 4'-substituted nucleosides |
| 07/28/2004 | CN1516589A N-biphenylcarbonyl-anjd N-phenylpyridylcarbonyl substituted bi-and tricyclic azepines and diazepines as vasopressing agonists |
| 07/28/2004 | CN1516588A Combination of brimonidine and timolol for topical ophthalmic use |
| 07/28/2004 | CN1516587A Quinazoline derivatives capable of promoting release of parathyroid |
| 07/28/2004 | CN1516586A Novel oral general anesthetics and metabolitically resistant anticonvulsants |
| 07/28/2004 | CN1516585A Process for preparing paroxetine HCI which limits formation of pink colored compounds |
| 07/28/2004 | CN1516584A Spiropyrazole compounds |
| 07/28/2004 | CN1516583A Pharmaceutical compositions comprising chelidonine or derivatives thereof |
| 07/28/2004 | CN1516582A 抗病毒化合物 Antiviral compounds |
| 07/28/2004 | CN1516581A Amino-sulfonyl-containing active compound (COX-2 inhibitors), polyethylene glycol and removing free radical antioxidate and liquid |
| 07/28/2004 | CN1516580A Sulfonamides |
| 07/28/2004 | CN1516579A Compressible guaifenesin compositions and method for making same |
| 07/28/2004 | CN1516578A Process for preparation of dispersions |
| 07/28/2004 | CN1516576A Solid orally-dispersible pharmaceutical formulation |
| 07/28/2004 | CN1515674A Biological pure culture for Nocardia |
| 07/28/2004 | CN1515672A Human chemotactic factor beta-8, chemotactic factor beta-1 and macrophage inflammatory protein-4 |
| 07/28/2004 | CN1515591A Growth hormone and serum albumni recombinant fusion protein |
| 07/28/2004 | CN1515574A Substituted 7-acylamino-3-(methyldiazanediyl) methylcephalosporin and intermediate body with antibiotic action |
| 07/28/2004 | CN1515572A Carbocyclic nucleoside semi-sulfate and its application for curing viral infection |
| 07/28/2004 | CN1515571A Phenyl xanthine derivative |
| 07/28/2004 | CN1515570A Preparation method of pyrazolo [4,3-C] pyridine-3-ketone L-tartate |
| 07/28/2004 | CN1515567A New benzothiaheptylyin with ileal bile acid transfer and taurocholate absorption inhibitor activity |
| 07/28/2004 | CN1515566A Substituted chromene derivative for curing inflammation |
| 07/28/2004 | CN1515565A Sarcandra flavones coumarins total extract, its medicine composition and application |
| 07/28/2004 | CN1515564A Method for preparing sitaipulan |
| 07/28/2004 | CN1515563A Aryl substituted piperazine for curing benign prostatauxe |
| 07/28/2004 | CN1515562A Phenyl-and aminophenyl-alkyl sulfonamide and urea derivative |
| 07/28/2004 | CN1515559A Phenyl-and aminophenyl-alkyl sulfonamide and urea derivative |
| 07/28/2004 | CN1515556A Intermediate compound for preparing aryl substituted piperazine |
| 07/28/2004 | CN1515555A Method for preparing 7-bromine quinolone carboxylic acid derivative or its salt |
| 07/28/2004 | CN1515554A Intermediate compound for producing 2-amino-6-(2-substituted-4-phenoxy) substituted pyridine compound |
| 07/28/2004 | CN1515553A Piperidine derivative crystal, midbody for preparation and preparing method |
| 07/28/2004 | CN1515551A 1,2-indane or indoline derivative |
| 07/28/2004 | CN1515550A Thrombosis resisting preparation |
| 07/28/2004 | CN1515548A Oxaminic acid used as thyroid gland receptor ligand and its derivative |
| 07/28/2004 | CN1515534A Non-cyclic 1,3-dicarbonyl PPAR double-activation compound with sugar-reducing lipid-reducing activity and preparation method of its medicinal preparation |
| 07/28/2004 | CN1515317A Combined therapeutic method for osteoporosis |
| 07/28/2004 | CN1515316A Combined therapeutic method for osteoporosis |
| 07/28/2004 | CN1515294A Solid preparation containing extract of three-bristle cudrania and its preparation method |
| 07/28/2004 | CN1515288A Medicine for curing catarct, its preparation method by using scutellaria root and medicine application |
| 07/28/2004 | CN1515277A Method for extractings ubstance resisting respiratory syncytial virus from patrinia |
| 07/28/2004 | CN1515267A Health plaster with the functions of promoting blood circulation and discharging toxicity |
| 07/28/2004 | CN1515265A Application of Chinese medicine polysaccharide as colonic drug-transferring carrier |
| 07/28/2004 | CN1515264A Breviscapine slowly-releasin tablet and its preparation method |
| 07/28/2004 | CN1515263A Phytosterol and phytosterol-beta-D-heteroside preparation and its application |
| 07/28/2004 | CN1515262A Adfuwei ester enteric soluble preparation |
| 07/28/2004 | CN1515261A Topical medicine composite containing cholinergic drug or calcium channel paralyser |
| 07/28/2004 | CN1515260A Cinnarizine powder injection containing HPCD, its solid preparation and preparation method |
| 07/28/2004 | CN1515259A 4-aminosubstituted-2-substituted-1,2,3,4-tetrahydroquinoline used as CETP inhibitor |
| 07/28/2004 | CN1515258A Combined therapeutic method for osteoporosis |
| 07/28/2004 | CN1515257A Paroxetine control-released composite |
| 07/28/2004 | CN1515256A Application of estrogen antagonist and estrogen excitent for inhibiting pathological disease |
| 07/28/2004 | CN1515255A Tannic acid berberine lozenge, its preparation method and application |
| 07/28/2004 | CN1515254A Combined therapeutic method for osteoporosis |
| 07/28/2004 | CN1515253A New application of 1,3-propylene glycol derivative |
| 07/28/2004 | CN1515252A Application of indole derivative as SHTI excitomotor |
| 07/28/2004 | CN1515251A Composition with function of beautifying face and its application |
| 07/28/2004 | CN1515250A New houttuynin sodium injection preparation and its preparation method |
| 07/28/2004 | CN1515249A Amino acid nutrient enriching agent and its preparation method |
| 07/28/2004 | CN1515248A Urea derivative used as inosine-5'-dehydrogenase monophosphate inhibitor |
| 07/28/2004 | CN1515246A New preparation of medicine, its preparation and application method |
| 07/28/2004 | CN1515244A Protein-stable pharmacological active matter, its preparation and application method |
| 07/28/2004 | CN1515242A Method and composition for whiting skin |
| 07/28/2004 | CN1159453C Methods for identifying pathogenic markers in sample o normal cells |
| 07/28/2004 | CN1159337C Steroides sulfatase inhibitors and methos for making and using same |
| 07/28/2004 | CN1159330C Anticancer presursor compound containing anthracycle cytotoxins, its preparing process and itd medicine |
| 07/28/2004 | CN1159327C Oligose with anticancer activity used as medicines or health-care products to improve immunity |
| 07/28/2004 | CN1159326C Process of extracting tannic acid from granium wilfordii root |
| 07/28/2004 | CN1159318C Metal protease inhibitor, preparing process thereof and pharmaceutical composition contg. same |
| 07/28/2004 | CN1159316C Iso-Indolo-indolone compound, their preparation methods and drug compositions comprising the same |
| 07/28/2004 | CN1159315C 4,5-pyrrolo-oxindoles |
| 07/28/2004 | CN1159314C Thiazolidinedione derivs. as antidiabetic agents |
| 07/28/2004 | CN1159313C Alkali-metal or alkali-earth metal salt of polyprotic acid delotadine and its medical composition |
| 07/28/2004 | CN1159312C Novel poyrimidine derivatives and process for preparation thereof |
| 07/28/2004 | CN1159311C Dihydropyrimidines |
| 07/28/2004 | CN1159307C Method for preparing xitaipulan |
| 07/28/2004 | CN1159306C Substituted 8,8a-dihydro-3aH-indeno[1,2-D] thiazoles, a method for their production and their use as medicaments |
| 07/28/2004 | CN1159303C Preparation of intermediate for monocyclic beta-lactams antibiotic derivatives |
| 07/28/2004 | CN1159300C Crystal modification of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and its use as antiepileptic |
| 07/28/2004 | CN1159299C Arylakylpyridzinones |
| 07/28/2004 | CN1159295C Inhibitors of metalloproteinases |
| 07/28/2004 | CN1159293C 5-aroylnaphthalene derivatives |
| 07/28/2004 | CN1159292C Aryl substitued cyclic amines as selective dopamine D3 ligands |
| 07/28/2004 | CN1159289C C-terminal modified oxamyl dipetides as inhibitors of the ICE/ced-3 family of cystenine proteases |
| 07/28/2004 | CN1159287C Anticonvulsant and sentral nervous system-active bis (fluorophenyl) alkylamides |
| 07/28/2004 | CN1159281C Composition containing conjugated calcium linoleate and making method thereof |
| 07/28/2004 | CN1159277C New intermediate for preparation of anti-histamine piperdine derivatives |
| 07/28/2004 | CN1159061C Treatment of infarcts through inhibition of NF-KAPPAB |
| 07/28/2004 | CN1159055C Medicine for treating beriberi and its preparing process |
| 07/28/2004 | CN1159053C Compoiste bear gall spray for treating rhinocleisis and its preparing process |
| 07/28/2004 | CN1159032C Exterior-applied plaster for treating lumber vertebra disease, cervical vertebra disease and osteoarthropathy and ite preparing process |
| 07/28/2004 | CN1159022C Ginkgo leaves composition and preparation method and uses |